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In tracheo esophageal puncture (TEP), we carry out a 
myotomy of the pharynx constrictor muscle; however, about 
9 to 79% of patients need such procedure. The consequence 
of such procedure is an increase in salivary fistula rates in the 
postoperative. Botulin toxin is used in an outpatient basis. 
Aim: analyzing the efficacy of botulin toxin (BT) use in the 
rehabilitation of totally laryngectomized patients with tracheo-
esophageal voice (TEV) with spasms (S) of the pharyngo-
esophageal segment (PES) without myotomy. Materials 
and Methods: We analyzed eight patients submitted to 
total laryngectomy (TL), rehabilitated with TEV, with speech 
prosthesis (SP) and struggle to utter voice because of PES 
spasms. They were all submitted to treatment of such motor 
alteration with the injection of 100 units of BT in the PES. 
The evaluation was based on perceptive voice analysis, 
video fluoroscopy (VF) of the PES, acoustic voice analysis 
and computerized manometry (CM) of the PES, all before 
and after BT injection. Study design: prospective. Results: 
There was a reduction in PES CM pressure after BT injection. 
Acoustic analysis showed an improvement in harmonics 
quality after treatment. There was smoother voice utterance 
and spasm improvement after BT. Conclusion: all patients 
with PES spasms presented vocal improvement after BT 
injection in the PES. 
Keywords: laryngeal cancer, total laryngectomy, botulinum 
toxin, voice, head and neck, tracheoesophageal speech.
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INTRODUCTION
About 9% to 79% of total laryngectomy (TL) pa-
tients undergoing rehabilitation with tracheoesophageal 
voice (TEV), phonatory prostheses (PP), and primary or 
secondary tracheoesophageal needle puncture (TEP), 
present effort-induced phonatory difficulties associated 
with motility alterations in the pharyngoesophageal seg-
ment (PES) secondary to spasm of this segment.1-13 There 
are three approaches for the treatment of PES alterations: 
myotomy of the middle and lower constrictors of the 
pharynx, neurectomy of the pharyngeal plexus, and the 
recently described chemical denervation of the PES with 
the botulinum toxin (BT).6,7,8,10,11,14-23 The BT is a presynaptic 
blocker of acetylcholine release at the neuromuscular junc-
tion. Videofluoroscopy3,4,7,15,24 and computed manometry 
(CM) demonstrate relaxation of the PES following the use 
of BT in this region. There are indirect assessment metho-
ds of the PES pressure, such as the modified esophageal 
insufflation test,4,6,15 measurement of intratracheal pressure 
and the phonation time.7,18 The purpose of this study was 
to assess the efficacy of the BT in TL patients rehabilitated 
by TEV with PP that presented emission of voice under 
effort due to spasm of the PES.
MATERIAL AND METHOD
Eight TL patients rehabilitated by TEV with PP that 
presented excessive effort for voice emission and an almost 
absent maximum phonation time were selected from 71 
TL patients that were similarly rehabilitated. All patients 
used an indwelling Blom-Singer (Inhealth®) PP, inserted 
after primary or secondary TEP.
The Research Ethics Committee of the local institu-
tion approved this study (protocol number 546/2005). All 
patients signed a free informed consent form.
Testing was composed of perceptive voice analysis, 
measurement of the mean phonation time (mean of three 
consecutive measurements using a professional chrono-
meter), swallowing and phonation testing by videofluo-
roscopy, four-channel CM, and computed acoustic voice 
analysis before and after injecting 100U of BT (Botox®) 
in the site of pharyngospasm. All patients also complained 
of mild dysphagia. BT was injected in each third of the 
PES (Figure 1) under electromyographic control of the 
pharyngeal constrictor muscles.
RESULTS
CM revealed a decrease in the mean PES pressure 
following BT injection in eight patients (Table 1, Figure 
2a and 2b).
Computed acoustic analysis demonstrated the pro-
duction of harmonics after BT injection in the PES of eight 
patients (Figure 3a and 3b). Harmonics were absent in 
these patients prior to therapy. Effortless voice production 
Figure 1. Representation of botulinum toxin injection areas in the three 
thirds of the pharyngoesophageal segment.
Table 1. Pharyngoesophageal segment pressure on computed 
manometry before (PRE) and after (POST) application of 100 U of 
the botulinum toxin.
 
 PATIENT PRE POST
1 33,0 mmHg 12,2 mmHg
2 17,27 mmHg 12,50 mmHg
3 16,79 mmHg 13,71 mmHg
4 32,7 mm Hg 19,6 mmHg
5 30,0 mmHg 14,1 mmHg
6 16,5 mmHg 13,6 mmHg
7 23,1 mmHg 15,4 mmHg
8 33,5 mmHg 13,4 mmHg
Figure 2a.
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and increased phonation time became possible in these 
patients (Table 2). Before BT therapy, the phonation time 
in all patients was one second. All patients reported im-
proved voice quality, as was demonstrated by the voice 
perception analysis. Videofluoroscopy of the PES during 
phonation showed that spasm of the PES decreased (Fi-
gure 4a and 4b). There were no adverse effects caused 
by the BT. There was clinical improvement of dysphagia 
in all patients.
Figure 2. Pressures in the pharyngoesophageal segment for each 
computed manometry channel before (a) and after (b) application of 
the botulinum toxin. Each baseline is one channel. Arrows on each 
baseline show the pharyngoesophageal pressure.
Figura 3a.
Figure 3. Computed acoustic analysis before (a) and after (b) injecting 
the botulinum toxin in the pharyngoesophageal segment. Harmonics 
were present after botulinum toxin injection (b), not visible before. An 
arrow shows a harmonic.
Table 2. Mean phonation time values, in seconds, before (PRE) and 
after (POST) application of 100 units of the botulinum toxin in the 
pharyngoesophageal segment.
 
Patient     
Phonation time, in 
seconds
PRE POST
1 1,0 9,0
2 1,0 7,0
3 1,0 7,0
4 1,0 7,5
5 1,0 8,0
6 1,0 8,5
7 1,0 6,8
8 1,0 7,0
DISCUSSION
PES spasm is one of the causes of failure in the 
rehabilitation of TL patients with TEV and PP.1-13 Altered 
PES motor activity in these cases is a reflex initiated by air 
entering the esophagus, blocking air from progressing to 
the pharynx. Consequently, the pharyngeal mucosa does 
not vibrate, and there is no phonation.1,3-5,7-9,13,18 Spasm may 
be seen in videofluoroscopy done during phonation with 
the PP;5,7,8,15,24 it is absent during swallowing when the PES 
relaxes. During constriction there is no relaxation when 
swallowing. In this case, therapy is dilatation.4,5,24 These are 
natural protecting mechanisms against gastropharyngeal 
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reflux; in TL patients, however, they become an obstacle 
against phonatory rehabilitation.7,8,13,24
BT injected in the PES was initially described in 
199425 for the treatment of swallowing disorders in which 
there was a hypertrophic or hypertonic upper esophageal 
sphincter. The dosages were 80 to 120 units. This method 
was first described for the treatment of PES spasm after 
TEP with PP in 1995.15 Some authors have shown effects 
lasting up to 2 years and 3 months with one initial dose 
only.17 A possible explanation for this is that after the first 
dose, patients adapt to the new condition;17 alternatively, 
denervation of the pharyngeal constrictor muscles due to 
presynaptic block by the BT might occur.
In primary TEP, myotomy of the middle and infe-
rior pharyngeal constrictor muscles is one of the surgical 
steps.10,26 This step may be related to a higher incidence of 
postoperative salivary fistulae.12,26 In such cases, hospital 
stay and medical expenses are increased, and phonatory 
rehabilitation, oral feeding and even the beginning of 
postoperative radiotherapy are delayed. The true need for 
myotomy in TEP is a controversial issue in the literature, 
varying from 9% to 79% in TL patients.1-13 In secondary 
TEP, myotomy is associated with a 10% to 20% incidence 
of salivary fistulae,26 with the same consequences mentio-
ned above. Using the BT for the treatment of PES spasm 
makes it possible to restrict myotomy for those patients 
that truly require this method for treating the PES; this 
avoids unnecessary procedures in the remaining patients, 
and reduces their surgery time and complication rate. 
Injection of the BT is done in an outpatient setting; the 
patient is seated and awake, and under electromyogra-
phic monitoring of the pharyngeal constrictor muscles. 
This procedure is less expensive than myotomy of the 
pharyngeal constrictor muscles.17 It should be borne in 
mind that even after myotomy of the middle and lower 
pharyngeal constrictor muscles, there may be spasm by 
reapproximation of muscle fibers.1,7,10,11,17 In such cases, 
the BT may also be used.
 CONCLUSION
The BT effectively decreased PES pressure in all 
patients, as assessed by CM.
All patients were able to produce harmonics follo-
wing application of the BT in the PES, as demonstrated 
by computed acoustic voice analysis.
Phonation time was increased in all patients follo-
wing application of the BT.
After injection of the BT, spasm of the PES decreased 
in all patients, as confirmed by videofluoroscopy.
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